As part of one of the world’s largest cardiac data networks, we support all major cardiovascular testing modalities for clinical trials including electrocardiography (ECG), event monitoring, blood pressure and Holter monitoring, as well as echocardiography (ECHO) and multi-gated acquisition scan (MUGA) testing. Additionally, we have a comprehensive portfolio of cardiac monitoring devices, including both site-based equipment and patient-centric, at-home devices for decentralized approaches to cardiac safety monitoring in clinical trials.
ECG
We support cardiac safety monitoring by offering a full range of ECG reading methodologies.
Event monitoring - CEM, TTM
A variety of event monitors can be used for all phases of clinical drug development and device studies.
Drug development studies, such as those for atrial fibrillation, are typically designed for patients to call in daily and in case of a dysrhythmia event.
Blood pressure monitoring (BPM)
Our blood pressure data upload system offers instant feedback to site personnel, even before data is transferred, enabling staff to make key decisions or perform additional procedures if needed..
Holter monitoring
Holter recordings, that can range from 24 to 48 to 72 hours and up to 7 days, are analyzed by cardiovascular medical doctors, then reviewed and authorized by a board-certified cardiologist or electrophysiologist, if required.
ECHO/MUGA
Experienced physicians perform all ECHO analyses, including quantification of cardiac chamber size, ventricular mass, cardiac function, volume and wall thickness.
